Human adipose tissue e derived mesenchymal stromal cells promote

Background aims. Mesenchymal stromal cells hold special interest for cell-based therapy because of their tissue-regenerative and immunosuppressive abilities. B-cell involvement in chronic inflammatory and autoimmune pathologies makes them a desirable target for cell-based therapy. Mesenchymal stromal cells are able to regulate B-cell function; although the mechanisms are little known, they imply cell-to-cell contact. Methods. We studied the ability of human adipose tissueederived mesenchymal stromal cells (ASCs) to attract B cells. Results. We show that ASCs promote B-cell migration through the secretion of chemotactic factors. Inflammatory/innate signals do not modify ASC capacity to mediate B-cell motility and chemotaxis. Analysis of a panel of B cellerelated chemokines showed that none of them appeared to be responsible for B-cell motility. Other ASC-secreted factors able to promote cell motility and chemotaxis, such as the cytokine interleukin-8 and prostaglandin E2, did not appear to be implicated. Conclusions. We propose that ASC promotion of B-cell migration by undefined secreted factors is crucial for ASC regulation of B-cell responses.

[1]  Manuel D. Díaz-Muñoz,et al.  Cyclooxygenase-2 Deficiency in Macrophages Leads to Defective p110γ PI3K Signaling and Impairs Cell Adhesion and Migration , 2013, The Journal of Immunology.

[2]  Lev Silberstein,et al.  Differential Stem and Progenitor Cell Trafficking by Prostaglandin E2 , 2013, Nature.

[3]  J. Grinyó,et al.  Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells , 2012, Front. Immun..

[4]  E. Lombardo,et al.  APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase. , 2012, Tissue engineering. Part A.

[5]  Yufang Shi,et al.  How mesenchymal stem cells interact with tissue immune responses. , 2012, Trends in immunology.

[6]  Koji Watanabe,et al.  IL-21–Dependent B Cell Death Driven by Prostaglandin E2, a Product Secreted from Follicular Dendritic Cells , 2011, The Journal of Immunology.

[7]  S. Morbelli,et al.  Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells , 2011, Proceedings of the National Academy of Sciences.

[8]  T. Ritter,et al.  Mesenchymal stem cell effects on T-cell effector pathways , 2011, Stem Cell Research & Therapy.

[9]  A. Marshak‐Rothstein,et al.  Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. , 2011, Seminars in immunology.

[10]  R. Yañez,et al.  Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. , 2010, Experimental cell research.

[11]  M. Shlomchik Activating systemic autoimmunity: B's, T's, and tolls. , 2009, Current opinion in immunology.

[12]  E. Lombardo,et al.  Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential. , 2009, Tissue engineering. Part A.

[13]  L. Moretta,et al.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.

[14]  S. Itakura,et al.  Mesenchymal stem cells suppress B-cell terminal differentiation. , 2009, Experimental hematology.

[15]  Yufang Shi,et al.  Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated Immunosuppression , 2009, Stem cells.

[16]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[17]  B. Blanco,et al.  The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes , 2008, Haematologica.

[18]  S. Kyurkchiev,et al.  Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen‐stimulated B‐cell immunoglobulin production in vitro , 2008, Cell biology international.

[19]  E. Lefèvre,et al.  BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. , 2008, Blood.

[20]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[21]  J. Cyster,et al.  Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. , 2008, Seminars in immunology.

[22]  L. Moretta,et al.  Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.

[23]  V. Levitsky,et al.  Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes , 2007, Journal of leukocyte biology.

[24]  O. Ringdén,et al.  Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells , 2007, Scandinavian journal of immunology.

[25]  J. Edwards,et al.  B-cell targeting in rheumatoid arthritis and other autoimmune diseases , 2006, Nature Reviews Immunology.

[26]  T. Luft,et al.  Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. , 2002, Blood.

[27]  B. Koller,et al.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.

[28]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[29]  C. Martínez-A,et al.  Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. , 1997, Journal of immunology.

[30]  K. Matsushima,et al.  Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects. , 1997, Journal of immunology.

[31]  A Orfao,et al.  Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic , 2010, Cytometry. Part B, Clinical cytometry.

[32]  Yoshiro Kobayashi The role of chemokines in neutrophil biology. , 2008, Frontiers in bioscience : a journal and virtual library.

[33]  F. Benvenuto,et al.  Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.

[34]  J. Frydenberg,et al.  CD19-selected B lymphocytes synthesize, secrete and migrate in the presence of IL-8. TNF-alpha and gammaIP-10 are also B lymphocyte migratory factors. , 1997, Cytokine.